Table 1 Baseline data of enrolled patients:
From: COVID-19 associated mucormycosis in Assiut University Hospitals: a multidisciplinary dilemma
COVID 19 (n = 400) | CAM (n = 33) | P value | |
|---|---|---|---|
Age (years) | 53 (18–92) | 58 (18–94) | 0.19 |
Sex | |||
Male | 175 (43.8%) | 21 (63.6%) | 0.02 |
Female | 225 (56.3%) | 12 (36.4%) | |
Occupation | |||
None | 295 (73.8%) | 25 (75.8%) | 0.49 |
Employee | 105 (26.3%) | 8 (24.2%) | |
Current smoking | 106 (26.5%) | 18 (54.5%) | < 0.001 |
Dyspnea | 400 (100%) | 33 (100%) | – |
Cough | 400 (100%) | 21 (63.6%) | < 0.001 |
Diabetes mellitus | 140 (35%) | 21 (63.6%) | < 0.001 |
Hypertension | 116 (29%) | 15 (45.5%) | 0.04 |
Renal disease | 28 (7%) | 3 (9.10%) | 0.42 |
Liver disease | 28 (7%) | 4 (12.12%) | 0.21 |
Cardiac disease | 17 (4.3%) | 3 (9.1%) | 0.18 |
Duration of symptoms (days) | 14.46 ± 1.78 | 14.82 ± 2 | 0.27 |